Therapeutic potential of natural compounds for treatment of chronic obstructive pulmonary disease: Current status and future perspective

被引:1
作者
Sahu, Sanjeev Kumar [1 ]
Rain, Musarraf [1 ]
Vyas, Manish [1 ]
机构
[1] Lovely Profess Univ, Sch Pharmaceut Sci, Jalandhar 144411, Punjab, India
来源
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS | 2024年 / 11卷
关键词
Chronic obstructive pulmonary disease; Oxidative stress; Reactive oxygen species; Genetic factors; Alpha-1 antitrypsin deficiency; Mitochondria dysfunction; Natural compounds; CIGARETTE-SMOKE; INFLAMMATION; EXTRACT; PATHOGENESIS; EMPHYSEMA;
D O I
10.1016/j.ejmcr.2024.100159
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Chronic obstructive pulmonary disease (COPD) is a lung disease which is the third most common cause of premature death globally. Inhaling dangerous gases, cigarette smoking, and exposure to pollution are the main factors contributing to the development of COPD. These factors may harm lung tissue and create COPD causes. Increased synthesis of inflammatory mediators and proteases because of cigarette smoking exposure to transcriptional factors. Dysfunction of mitochondria essential part to lead and development of several human illnesses, such as chronic obstructive pulmonary disease. Alpha-1 antitrypsin deficiency boosts neutrophil elastase activity, which promotes tissue deterioration and emphysema (particularly in smokers because cigarette smoke also boosts protease activity). In this review, we discussed all these factors and summarized the conventional drug currently present for the treatment of COPD. In addition, we also focused on various natural compounds categorized under the flavonoids, polyphenols, alkaloids, glycosides and marine compounds which were reported for the effective treatment of COPD.
引用
收藏
页数:10
相关论文
共 50 条
[21]   Molecular Approaches to Treating Chronic Obstructive Pulmonary Disease: Current Perspectives and Future Directions [J].
Vu, Sheryl-Phuc ;
Veit, Kaleb ;
Sadikot, Ruxana T. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (05)
[22]   The Current Molecular and Cellular Landscape of Chronic Obstructive Pulmonary Disease (COPD): A Review of Therapies and Efforts towards Personalized Treatment [J].
Farrell, Luke A. ;
O'Rourke, Matthew B. ;
Padula, Matthew P. ;
Souza-Fonseca-Guimaraes, Fernando ;
Caramori, Gaetano ;
Wark, Peter A. B. ;
Dharmage, Shymali C. ;
Hansbro, Phillip M. .
PROTEOMES, 2024, 12 (03)
[23]   Phenotyping of Chronic Obstructive Pulmonary Disease: Current Approaches and Future Directions [J].
Luis Lopez-Campos, Jose .
CURRENT RESPIRATORY MEDICINE REVIEWS, 2011, 7 (02) :138-143
[24]   Therapeutic RNA Strategies for Chronic Obstructive Pulmonary Disease [J].
Mei, Dan ;
Tan, W. S. Daniel ;
Tay, Yvonne ;
Mukhopadhyay, Amartya ;
Wong, W. S. Fred .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2020, 41 (07) :475-486
[25]   Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease [J].
Singh, Dave ;
Roche, Nicolas ;
Halpin, David ;
Agusti, Alvar ;
Wedzicha, Jadwiga A. ;
Martinez, Fernando J. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 194 (05) :541-549
[26]   The role of sulfur compounds in chronic obstructive pulmonary disease [J].
Jiang, Simin ;
Chen, Yahong .
FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
[27]   Chronic obstructive pulmonary disease (COPD) and its future [J].
Tatlicioglu, Turkan .
TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2007, 55 (03) :303-318
[28]   Neutrophils and emerging targets for treatment in chronic obstructive pulmonary disease [J].
Meijer, Mariska ;
Rijkers, Ger T. ;
van Overveld, Frans J. .
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2013, 9 (11) :1055-1068
[29]   Role of Diet in Chronic Obstructive Pulmonary Disease Prevention and Treatment [J].
Scoditti, Egeria ;
Massaro, Marika ;
Garbarino, Sergio ;
Toraldo, Domenico Maurizio .
NUTRIENTS, 2019, 11 (06)
[30]   Roflumilast for the treatment of chronic obstructive pulmonary disease [J].
Antoniu, SA .
CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2006, 7 (05) :412-417